Fair Accountability and Innovative Research Drug Pricing Act of 2019 or the FAIR Drug Pricing Act of 2019
This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2019-09-24 | Calendars | Placed on the Union Calendar, Calendar No. 170. | House floor actions |
| 2019-09-24 | Committee | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215. | House floor actions |
| 2019-07-17 | Committee | Ordered to be Reported (Amended) by Voice Vote. | House committee actions |
| 2019-07-17 | Committee | Committee Consideration and Mark-up Session Held. | House committee actions |
| 2019-07-11 | Committee | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . | House committee actions |
| 2019-07-11 | Committee | Subcommittee Consideration and Mark-up Session Held. | House committee actions |
| 2019-05-21 | Committee | Subcommittee Hearings Held. | House committee actions |
| 2019-04-15 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-04-12 | IntroReferral | Referred to the House Committee on Energy and Commerce. | House floor actions |
| 2019-04-12 | IntroReferral | Introduced in House | Library of Congress |